Mark R. Battig

机构：Children's Hospital of Philadelphia · ORCID：0000-0001-7831-6935

发表论文 23 篇 · 总被引 1127 次 · h-index 13

代表论文

• ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor (2019 · Nature Medicine · 被引 223)
• Aptamer-based molecular recognition for biosensor development (2010 · Analytical and Bioanalytical Chemistry · 被引 144)
• Programmable Hydrogels for Controlled Cell Catch and Release Using Hybridized Aptamers and Complementary Sequences (2012 · Journal of the American Chemical Society · 被引 137)
• Programmable Release of Multiple Protein Drugs from Aptamer-Functionalized Hydrogels via Nucleic Acid Hybridization (2012 · Journal of the American Chemical Society · 被引 133)
• Genomic profiling informs diagnoses and treatment in vascular anomalies (2023 · Nature Medicine · 被引 66)
• Aptamer-functionalized superporous hydrogels for sequestration and release of growth factors regulated via molecular recognition (2014 · Biomaterials · 被引 66)